MJ DAILY EUROPE
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis producers benefiting, only businesses that have marketable intellectual property and an established foothold in the medical cannabinoid arena will draw serious […] Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making? is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Excerpt only …
READ MORE BELOW
Source : Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
reposted by Cannabis News World